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Abstract  1 
Scope: Previous results suggested the effects of Salvia fruticosa tea (SFT) drinking on 2 
glucose regulation might be at the intestinal level. Here, we aim to characterize the 3 
effects of SFT-treatment and of its main phenolic constituent – rosmarinic acid (RA) – 4 
on the levels and localization of the intestinal Na+/glucose cotransporter-1 (SGLT1), 5 
the facilitative glucose transporter 2 (GLUT2) and glucagon-like peptide-1 (GLP-1). 6 
Methods and results: Two models of SGLT1 induction in rats were used: through 7 
diabetes induction with streptozotocin (STZ) and through dietary carbohydrate 8 
manipulation. Drinking water was replaced with SFT or RA and blood parameters, liver 9 
glycogen and the levels of different proteins in enterocytes quantified. Two weeks of 10 
SFT treatment stabilized fasting blood glucose levels in STZ-diabetic animals. The 11 
increase in SGLT1 localized to the enterocyte brush-border-membrane (BBM) induced 12 
by STZ treatment was significantly abrogated by treatment with SFT, without 13 
significant changes in total cellular transporter protein levels. No effects were observed 14 
on GLUT2, Na
+
/K
+
-ATPase or GLP-1 levels by SFT. Additionally, SFT and RA for 4 15 
days significantly inhibited the carbohydrate-induced adaptive increase of SGLT1 in 16 
BBM. 17 
Conclusion: SFT and RA modulate the trafficking of SGLT1 to the BBM and may 18 
contribute to the control of plasma glucose. 19 
 20 
 21 
 22 
 23 
 24 
 25 
 3 
1 Introduction 26 
Diabetes mellitus affects 10 to 20% of adults worldwide and is characterized by 27 
high levels of glucose in the blood. Particularly type 2 diabetes mellitus (T2DM), that 28 
corresponds to 90 to 95% of all cases of diabetes, is attaining epidemic proportions in 29 
populations with western-type diets and lifestyles [1], in part due to loss of traditional 30 
cooking with local ingredients, including herbs and spices. This justifies the search for 31 
new active principles and therapeutical targets that help prevent and limit the 32 
progression of this disease. Plants with antidiabetic reputation may be good sources of 33 
compounds with these properties.  34 
Herbs, such as ginseng (Panax spp.), fenugreek (Trigonella foenum graecum) 35 
and bitter melon (Momordica charantia) and spices, such as cinnamon (Cinnamomum 36 
zeylanicum), are examples of plants where antidiabetic properties have been identified 37 
in experimental animals and clinical trials with T2DM patients [2-5]. Salvia species, 38 
such as Salvia officinalis and Salvia fruticosa, have also been used for their antidiabetic 39 
properties [6, 7]. Because these plants are edible and palatable, they produce their 40 
effects by inclusion in the diet. However, active principles and mechanisms of action 41 
have not been elucidated. 42 
Glucose released upon carbohydrate digestion is absorbed mainly in the jejunum 43 
of the small intestine. The Na (+)-glucose cotransporter (SGLT1), localized to the 44 
enterocyte apical or brush-border membrane (BBM), and the basolateral facilitative 45 
glucose transporter 2 (GLUT2) are the main intestinal sugar transporters responsible for 46 
glucose uptake from the intestinal lumen into the blood [8]. The Na
+
 gradient necessary 47 
for SGLT1 activity is maintained by the basolateral Na
+
/K
+
-ATPase. 48 
The intestine has the ability to adapt functionally as well as morphologically to 49 
stimuli such as diet composition and disease processes, such as diabetes [9]. Induction 50 
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of SGLT1 expression in the BBM of enterocytes is produced by ingesting diets rich in 51 
carbohydrates that increase available luminal glucose [10].  In addition, an increase in 52 
SGLT1 expression in jejunal enterocytes is associated with diabetes in humans (4.3-fold 53 
in BBM [11]) and experimental animals, resulting in increased monosaccharide 54 
absorption [12]. GLUT2 levels have also been shown to be increased in the intestine of 55 
both diabetic rats and human patients [11, 12]. These changes combined with intestinal 56 
hyperplasia increase the capacity for glucose absorption in diabetic individuals, which 57 
aggravates undesirable postprandial hyperglycemia. Therefore, strategies that delay 58 
digestion and absorption of intestinal glucose are beneficial in a diabetes scenario. The 59 
delay of digestion is a therapeutic strategy currently addressed by the oral antidiabetic 60 
drug acarbose, an alpha-amylase and alpha-glucosidase inhibitor [13]. 61 
Also contributing to the diabetic postprandial hyperglycemia is a reduction in the 62 
incretin effect due to loss of insulin response to gastric inhibitory polypeptide and to a 63 
significantly reduced secretion of glucagon-like peptide 1 (GLP-1) [14]. New strategies 64 
to prevent the loss of GLP-1 producing cells would also be beneficial. 65 
The present study aims at characterizing the effects of greek sage (Salvia 66 
fruticosa Mill.) tea and rosmarinic acid (RA; corresponding to 72% of the total 67 
phenolics present in this tea) on intestinal expression of glucose transporters (SGLT1 68 
and GLUT2) and Na
+
/K
+
-ATPase in response to streptozotocin-induced diabetes and 69 
dietary carbohydrates. In view of the involvement of Hsp70 and PKC on the SGLT1 70 
activity and vesicle trafficking to the BBM, effects on the expression levels of these 71 
proteins were also determined. Effects on GLP-1 and pancreatic islet regeneration were 72 
evaluated as well. 73 
 74 
2 Materials and methods 75 
 5 
2.1 Plant material and preparation of S. fruticosa water extract  76 
Salvia fruticosa plants were cultivated in an experimental farm located in Merelim, 77 
Braga, Portugal, and were collected in June 2004. The aerial parts of plants were air 78 
dried and kept a -20ºC with the accession number SF062004, under the responsibility of 79 
the Centre for the Research and Technology of Agro-Environmental and Biological 80 
Sciences (CITAB), University of Minho. Voucher specimen is also kept in an active 81 
bank in Braga, Portugal, also under the responsibility of the CITAB. 82 
Since sage is traditionally used as a tea, a water extract of S. fruticosa was routinely 83 
prepared as previously described [15] by pouring 150ml of boiling water onto 2g of the 84 
dried plant material and allowing to steep for 5 min. The preparation produced a 85 
2.8±0.1mg of extract dry weight per ml of infusion (0.28% w/v) and a yield of 19.1% 86 
(w/w) in terms of initial crude plant material of S. fruticosa. Sub-samples of freeze-87 
dried extract (0.01g) were redissolved in 1ml of ultrapure Milli Q water and aliquots of 88 
20µl were injected into the HPLC/DAD system and analyzed by HPLC/DAD as 89 
previously described [16]. Rosmarinic acid (577.29g/ml), 6-hydroxyluteolin-7-90 
glucoside (104.78g/ml) and a heteroside of an unidentified flavone (99.13g/ml) were 91 
the most representative phenolic compounds. 92 
 93 
2.2 Animals 94 
Male Wistar rats (6 weeks) were purchased from Charles River Laboratories 95 
(Barcelona, Spain) and kept in the authorized animal facilities of the Life and Health 96 
Sciences Research Institute (ICVS) from University of Minho. The animals were 97 
maintained under controlled temperature (20±2ºC) and humidity (55±10%) with a 12 h 98 
light:12 h dark cycle, and given food and tap water ad libitum. Animals were kept and 99 
handled in accordance the NIH guidelines for the experimental use and care of 100 
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laboratory animals by authorized investigators by the National Veterinary Agency 101 
(DGV: Direcção Geral de Veterinária), Portugal, and the experiment approved by the 102 
university’s ethics committee. 103 
Diabetes was induced by a single i.p. injection of freshly prepared streptozotocin (STZ, 104 
Sigma-Aldrich, St. Louis, MO, USA) solution (45mg/Kg in 0.1M acetate buffer, pH 4.5 105 
given in a volume of 1ml/Kg body weight [17]) to overnight-fasted rats. Control 106 
animals received a sham injection with buffer only. Diabetes was identified by 107 
polydipsia, polyuria and by measuring non-fasting plasma glucose levels 48 h after 108 
injection of STZ. One week after STZ injection, rats with fasting blood glucose levels 109 
of 250-350mg/dl were used in the experiment. 110 
 111 
2.3 Experimental design  112 
2.3.1 Diabetic animals induced by STZ were used as a model of SGLT1 induction in 113 
intestinal mucosa. Twenty four rats were used and divided into four groups (two healthy 114 
and two STZ-diabetic) of six rats each. Animal groups were subjected to the following 115 
treatments for 14 days (Fig. 1A): group 1 – healthy rats drinking water; group 2 – 116 
healthy rats drinking S. fruticosa tea (SFT); group 3 – STZ-induced diabetic rats 117 
drinking water; group 4 – STZ-induced diabetic rats drinking SFT. Water/SFT (made in 118 
tap water) and food were given ad libitum and the beverage was renewed daily. Due to 119 
the diabetic-induced polydipsia, SFT was diluted in group 4 in order to give the same 120 
dose as in group 2, based on the beverage consumption measured in the previous day. 121 
The replacement of water by SFT did not change food and beverage consumption, or 122 
animal body weight increase.  123 
At the end of the treatment, 16 h-fasted animals were sacrificed by decapitation and the 124 
intestinal mucosa (40cm of jejunum) scraped off on ice with a glass microscope slide, 125 
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after washing with PBS pH 7.4 (containing 40mM PMSF in ethanol added fresh). The 126 
intestinal mucosa was immediately frozen in liquid nitrogen and stored at -80ºC until 127 
use. Prior to scraping a small piece of intact jejunum (from the middle of the above 128 
40cm region) was collected as well as pancreatic tissue for fixation in 4% 129 
paraformaldehyde in PBS pH 7.4, for 24 h at 4ºC. The tissues were then stored in 130 
ethanol 70% (v/v) until being processed for paraffin embedding. Blood samples were 131 
also collected to measure glucose and insulin levels, as well as the activity of liver 132 
transaminases. 133 
2.3.2 An additional model of SGLT1 induction in intestinal mucosa through dietary 134 
carbohydrate manipulation was used. For that, thirty rats were used and divided into 135 
five groups of six animals each, where (Fig. 1B): group 1 – rats were fed with water and 136 
food (normal rat chow – referred as high carbohydrate diet – HC) ad libitum for 14 137 
days; group 2 – rats were fed with water and food (HC) ad libitum for 7 days, and 138 
afterwards fed for 7 days with a soybean diet (low carbohydrate diet – LC) replacing the 139 
normal rat chow ad libitum; group 3 – rats were treated as in group 2, and afterwards 140 
fed for 4 days more with water and HC diet ad libitum; group 4 – rats were treated as in 141 
group 2, and afterwards fed for 4 days more with daily fresh S. fruticosa tea (replacing 142 
the water drinking) and HC diet ad libitum; group 5 – rats were treated as in group 4, 143 
with daily fresh RA solution replacing the S. fruticosa tea drinking. The RA solution 144 
was prepared in tap water diluting RA (Sigma-Aldrich) to the same concentration found 145 
in the SFT (577μg/ml).  146 
The composition of the food given to the rats are presented in Supporting 147 
Information Table 1, where the normal rat chow (UAR-A04 chow diet, Reus, Spain) 148 
with 60.3% carbohydrates was considered the HC diet and the soybean diet with 28.0% 149 
of carbohydrates was referred as LC diet (Soybean meal 47.5, Cargill S.A.C.I., Buenos 150 
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Aires, Argentina, kindly supplied by NANTA, Fábricas de Moagem do Marco S.A., 151 
Marco de Canaveses, Portugal). 152 
Animals were sacrificed by decapitation and the intestinal mucosa (40cm of jejunum) 153 
was scraped off and stored as in the previous experiment. Blood samples were also 154 
collected to measure plasma glucose levels. 155 
 156 
2.4 Isolation of Brush-Border Membranes 157 
Brush-Border Membranes (BBM) were isolated from frozen jejunal mucosal scrapings 158 
using a combination of cation precipitation and differential centrifugation as described 159 
previously [18] with few modifications (for details, see Supporting Information 160 
Materials and methods). BBM were then frozen in liquid nitrogen and stored at -80ºC 161 
until use. The enrichment of the brush-border marker (by measuring the activity of 162 
alkaline phosphatase [19]) was about 10 times the mucosa crude homogenate. Protein 163 
content was measured with the Bradford Reagent (Sigma-Aldrich) using BSA as a 164 
standard. 165 
 166 
2.5 Western blotting  167 
The levels of SGLT1, GLUT2 and Hsp70 in the BBM was quantified by Western 168 
blotting as described previously [20, 21]. BBM protein were solubilized in Laemmli’s 169 
buffer [22] and heated for 15 min at 70ºC. Then, 25µg of protein were loaded in each 170 
well and separated by SDS-PAGE and transferred onto Hybond-P polyvinylidene 171 
difluoride membrane (GE Healthcare, Buckinghamshire, UK). Membranes were 172 
blocked in 5% (w/v) non-fat dry milk in TPBS (0.05% (v/v) Tween 20 in PBS) pH 7.4, 173 
for 1 h, at room temperature and then incubated with rabbit antibody to rat SGLT1 174 
(raised in rabbits against a peptide comprising amino acids 582-600: 175 
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EEDPKDTIEIDAEAPQKEK of rat SGLT1 [23]) or rabbit polyclonal to SGLT1 176 
(Abcam, Cambridge, UK) diluted 1:500 or 1:2,000, respectively, overnight at 4ºC. After 177 
secondary antibody incubation, immunoreactive bands were detected by 178 
chemiluminescence exposing to a film. Membranes were also probed against GLUT2 179 
(using rabbit polyclonal antibody from Chemicon International, Temecula, CA, USA) 180 
and Hsp70 (using a mouse monoclonal antibody from Sigma-Aldrich). 181 
The same procedure was used to quantify the abundance of SGLT1, GLUT2, Hsp70, 182 
Na
+
/K
+
-ATPase (using α5 mouse monoclonal antibody [24]) and PKC (using a rabbit 183 
polyclonal antibody; Chemicon International, Temecula, CA, USA) in whole cell 184 
homogenates of jejunal mucosa. The Na
+
/K
+
-ATPase antibody was obtained as culture 185 
supernatant from the Developmental Studies Hybridoma Bank, University of Iowa, 186 
Iowa City, under contract N01-HD-7-3263 from The National Institute of Child Health 187 
and Human Development. 188 
The intensity of the immunoreactive bands was measured from digitized images, 189 
calibrated with a Kodak grey scale, using Sigma Scan Pro (v5) software (SPSS, 190 
Chicago, IL, USA), or acquired by a chemiluminescence detection system, the Chemi 191 
Doc XRS (BioRad Laboratories, Inc., Hercules, CA, USA), being the band area 192 
intensity quantified using the Quantity One software from BioRad. Results are 193 
presented as percentage of band area intensity of controls. 194 
 195 
2.6 Glucose measurement 196 
In the experiment of STZ-diabetic rats, blood glucose levels from overnight fasted 197 
animals were monitored with the Accutrend® GCT device (Roche diagnostics GmbH, 198 
Mannheim, Germany) using Accutrend® test strips for glucose (Roche diagnostics 199 
GmbH), during the experimental period. 200 
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In the diet manipulation experiment, plasma glucose levels from ad libitum fed animals 201 
were measured using a colorimetric enzymatic method – Glucofix (A. Menarini 202 
Diagnostics, Firenze, Italy) – following manufacturer specifications. 203 
 204 
2.7 Insulin measurement 205 
The content of insulin in rat plasma was measured using an ELISA-based commercial 206 
kit – Rat Insulin EIA Kit (SPI-BIO, Montigny-le-Bretonneux, France) – following the 207 
manufacturer specifications. 208 
 209 
2.8 Liver glycogen content 210 
Liver glycogen content was quantified with amyloglucosidase as previously described 211 
[25]. Dilutions of the liver homogenate were used to ensure that the determination was 212 
done within the linear phase. The glycogen content was expressed in μmol glucose per g 213 
of liver. 214 
 215 
2.9 Statistical Analysis 216 
Data are expressed as means with standard errors of the means (SEM). 217 
For statistical analysis a two-way ANOVA was employed followed by the Newman-218 
Keuls multiple comparison test (SigmaStat, version 2.03; SPSS Inc., San Rafael, CA, 219 
USA) to compare physiological conditions (healthy vs. diabetic) and the effect of in 220 
vivo beverage (water vs. SFT). P values ≤ 0.05 were considered statistically significant. 221 
Student t-tests were used to compare differences within the different carbohydrate 222 
groups, namely HC-HC, HC-LC and HC-LC-HC/W groups. Then, to compare the 223 
effects of different drinking regimes (water-W; S. fruticosa tea-T; and, rosmarinic acid-224 
RA) within the HC-LC-HC carbohydrate groups, a one-way ANOVA followed by the 225 
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Newman-Keuls multiple comparison test were employed. P values ≤ 0.05 were 226 
considered statistically significant. 227 
 228 
3 Results 229 
3.1 SFT treatment significantly improves diabetic fasting blood glucose levels, but 230 
has no effects on plasma insulin and liver glycogen content  231 
As expected, one week after the i.p. injection of STZ, fasting blood glucose increased 232 
from about 119 ± 4 mg/dl in healthy rats to 311 ± 25 mg/dl in STZ-induced diabetic 233 
animals (Fig. 2A). Plasma insulin concentration was significantly lower in diabetic 234 
versus non-diabetic animals (Fig. 2B). In water drinking STZ-diabetic animals plasma 235 
glucose levels continued to increase throughout the 14 day experimental period but 236 
remained stable in SFT drinking STZ-diabetic animals (Fig. 2A). On day fourteen, SFT-237 
treated diabetic animals showed significantly lower blood glucose levels than water 238 
drinking controls (Fig. 2A). In non-diabetic (healthy) animals, fasting glucose levels 239 
remained constant and were not affected by SFT drinking. 240 
SFT drinking did not significantly changed liver glycogen content (Fig. 2C) or induced 241 
liver toxicity (monitored by plasma transaminase levels – (Supporting Information 242 
Table 2) or increased regeneration of beta-cell mass (Supporting Information Fig. 1). 243 
 244 
3.2 SFT treatment decreases enterocyte BBM SGLT1 in diabetic animals but has 245 
no effects on healthy animals 246 
As shown in Fig. 3, STZ-diabetic rats showed a significant increase in SGLT1 levels 247 
both in whole cell homogenates (40%) and in BBM (85%), when compared with 248 
controls. Treatment with SFT for 14 days did not change SGLT1 levels in whole cell 249 
homogenates (Fig. 3A), but limited the increase in BBM to about 30% of levels in 250 
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untreated controls (Fig. 3B). In healthy animals sage tea drinking did not change 251 
SGLT1 levels. 252 
In addition to its presence on the basolateral membrane, GLUT2, alongside SGLT1, 253 
may play a role in intestinal glucose absorption at the BBM [11, 12, 26], where its 254 
abundance has been shown to increase with diabetes induction [26]. The levels of 255 
GLUT2 were significantly increased in whole cell homogenates of jejunal mucosa of 256 
STZ-diabetic rats when compared with healthy controls (Fig. 4A) but not in BBM 257 
(Supporting Information Fig. 2). Levels of Na
+
/K
+
-ATPase were higher in diabetic 258 
animals (Fig. 4B) and the number of GLP-1 expressing cells per cm of villus, 259 
determined by immunohistochemistry (Supporting Information Fig. 3), was smaller in 260 
diabetic animals compared with healthy controls. All these parameters were not affected 261 
by SFT treatment. 262 
 263 
3.3 SFT and particularly rosmarinic acid decrease fed state plasma glucose levels 264 
in animals fed a high carbohydrate diet 265 
As shown in Fig. 5, feeding the LC diet for 7 days (HC-LC group) produced a 266 
significant 15% reduction in plasma glucose levels (in fed animals), when compared 267 
with HC-HC group. Four days after the reintroduction of the HC diet (HC-LC-HC 268 
group), plasma glucose returned to control levels. However, in the RA group, the return 269 
of plasma glucose to control levels was completely inhibited (Fig. 5). 270 
 271 
3.4 SFT and rosmarinic acid significantly decrease SGLT1 in BBM but not total 272 
enterocyte SGLT1 levels in high carbohydrate fed animals 273 
SGLT1 levels in the BBM of enterocytes increase with increasing digestible dietary 274 
carbohydrates and can be down regulated by removing carbohydrate from the diet. Four 275 
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days (but not 2; see Supporting Information Fig. 4) after the reintroduction of a high 276 
carbohydrate diet (HC) to animals where enterocyte BBM and total SGLT1 levels had 277 
been dramatically reduced (by feeding a low carbohydrate (LC) diet for 7 days) resulted 278 
in complete recovery of SGLT1 levels (Fig. 6). Replacing water with SFT or RA upon 279 
reintroduction of the HC diet caused a significant inhibition of the adaptive increase of 280 
SGLT1 levels in BBM of about 32% and 50%, respectively (Fig. 6B), without affecting 281 
total levels (Fig. 6A).  282 
 283 
3.5 SFT and rosmarinic acid decrease BBM Hsp70 and PKC levels 284 
As shown in Fig. 7, the levels of the constitutive form of Hsp70 in BBM, which 285 
corresponds to only a small part of total Hsp70 (Fig. 7C), decreased significantly in LC 286 
fed animals, but returned to normal levels 4 days after the reintroduction of HC diet. 287 
SFT and RA treatments inhibited this recovery, the effect being significant for RA. The 288 
levels of Hsp70 in whole cell homogenates were not changed among the different 289 
groups (Supporting Information Fig. 5). PKC levels (Fig. 8) were not affected by diet, 290 
but were significantly lower in RA-treated animals. 291 
 292 
4. Discussion 293 
Control over carbohydrate digestion and absorption is beneficial in the 294 
management of diabetes since it helps contain postprandial hyperglycemia excursions 295 
thereby improving glycemic control and reducing the risk of diabetic complications 296 
[27]. Many studies have reported that diabetes enhances intestinal glucose absorption, 297 
although the mechanisms that underlie this effect are poorly understood. Higher levels 298 
of intestinal BBM glucose transporters in both diabetic patients and experimental 299 
diabetic animals [11, 12, 26, 28], contributes significantly to the increased glucose 300 
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absorption in diabetes. However, there are, to our knowledge, no therapeutic attempts to 301 
limit it. Inhibitors of SGLT1, such as phloridzin, have been known, although its 302 
degradation by intestinal lactase-phloridzin hydrolase has been pointed out to limit its 303 
pharmacological value. Inhibition of SGLT1 activity by other natural compounds, such 304 
as tea polyphenols (e.g. epigallocatechin gallate) has also been shown [29]. However, 305 
few studies show effects on SGLT1 levels in the BBM, where it is functionally active. 306 
Recently, Gum Arabic has been shown to produce this effect [30]. Also, Miró-Queralt 307 
et al. [31] also reported that sodium tungstate normalized SGLT1 expression in the 308 
jejunum of STZ-diabetic rats. 309 
Fourteen days of treatment with SFT presented no toxicity (plasma 310 
transaminases not changed) and prevented further deterioration of glucose homeostasis 311 
in STZ diabetic rats without affecting plasma insulin levels or liver glycogen deposition. 312 
In a previous report [6], SF water extracts was shown to decrease plasma glucose after 313 
an oral glucose tolerance test but not an intravenous glucose tolerance test, suggesting 314 
SFT acts at the intestinal level rather than by improving peripheral insulin sensitivity.  315 
Because the intestinal effects are not due to digestive enzyme inhibition 316 
(unpublished observations), in the present study, we hypothesized that SFT would exert 317 
control over blood glucose through modulation of enterocyte glucose transporter levels. 318 
To test this, two models of SGLT1 induction in rats were used: diabetes induction with 319 
STZ and dietary carbohydrate manipulation. 320 
As expected, three weeks after STZ administration to rats plasma glucose was 321 
elevated, plasma insulin decreased, and enterocyte total and BBM levels of SGLT1 322 
were increased, associated with diabetes induction. SFT drinking for 14 days in diabetic 323 
animals significantly decreased SGLT1 levels at the BBM but not in mucosa whole cell 324 
homogenates. This suggests effects of SFT on SGLT1 trafficking but not on total 325 
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protein levels. Because SFT reduced BBM SGLT1 levels in diabetic animals but had no 326 
effects in healthy controls, this plant extract seems to act only when the mechanisms of 327 
induction of BBM expression of intestinal glucose transporters are activated and does 328 
not affect basal expression levels. 329 
To confirm the effect of SFT on the regulation of SGLT1 BBM levels, a model 330 
of its induced expression by dietary carbohydrate manipulation was used. As in the 331 
diabetic animals, SFT treatment significantly inhibited the increase of SGLT1 levels in 332 
the BBM after HC reintroduction, but not in whole cell homogenates. In an attempt to 333 
identify the active principle present in SFT, its main phenolic compound – RA – was 334 
used and shown to have an even stronger effect than the plant extract. The lower 335 
expression of SGLT1 in the BBM of RA-treated group was associated with a significant 336 
decrease of non-fasting plasma glucose levels measured in this group. 337 
Our results indicate that SFT, and RA in particular, control the transporter levels 338 
at the BBM by decreasing it in conditions where it is enhanced, such as in diabetes and 339 
during adaptation to increased digestible carbohydrate in the diet. These effects on the 340 
trafficking of SGLT1 at intestinal level, are paralleled by decreases in blood glucose and 341 
identified RA as an active principle 342 
There were no SFT effects on GLUT2 levels (total or BBM) that were only 343 
slightly increased (not in BBM) in diabetic animals. Intestinal BBM GLUT2 has been 344 
reported to be elevated in insulin resistant diabetic animals where the levels are not 345 
reduced by insulin treatment [28], contrary to levels of BBM SGLT1 that decrease upon 346 
insulin administration [32]. 347 
In agreement with previous reports [33], the intestinal level of Na
+
/K
+
-ATPase 348 
increased in association with diabetes. SFT treatment did not normalize these levels. 349 
Effects on the incretin hormone GLP-1 would also be important components of any 350 
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intestinal effects of SFT. The incretin hormone GLP-1 potentiates the glucose-induced 351 
insulin secretion by the beta-cells where it also has trophic effects [34, 35], and inhibits 352 
glucagon secretion, which justifies its clinical importance in the treatment of diabetes 353 
[36]. The number of GLP-1 expressing cells per cm of villus in diabetic animals was, 354 
however, not changed by SFT treatment. 355 
The high antioxidant content of the sage extract [15] may contribute for the 356 
protection/regeneration of insulin-producing beta-cells. Antioxidants reduce oxidative 357 
stress and decrease glucotoxicity in pancreatic beta-cells, which have low antioxidant 358 
defenses [37]. There were, however, no changes in pancreatic beta-cell mass in diabetic 359 
animals after introduction of SFT treatment indicating no increased regeneration of the 360 
insulin producing cells by SFT. 361 
In order to shed light on the mechanisms of S. fruticosa and RA on translocation 362 
to the BBM of SGLT1, heat shock protein 70 (Hsp70) and protein kinase C (PKC) were 363 
quantified. Hsp70 has been reported to increase both translocation of SGLT1 to the 364 
BBM and transport activity, through the formation of Hsp70/SGLT1 complexes [38, 365 
39]. Our results show that Hsp70 levels profile in BBM was similar to that of SGLT1. 366 
This indicates that SGLT1 translocation and stabilization to the BBM may, in fact, be 367 
involved in the observed SFT effects. 368 
PKC is implicated in the regulation of vesicle translocation containing glucose 369 
transporters such as GLUT4 and GLUT2 [40-42]. It is well established that insulin leads 370 
to the activation of atypical PKC and/or Akt (PKB), which results in the translocation of 371 
GLUT4 from intracellular pools to the plasma membrane of myocytes or adipocytes 372 
[41]. SGLT1 transporters reside also intracellularly in microtubule-associated vesicular 373 
structures, and respond to mechanisms of vesicle trafficking [43]. However, insulin 374 
signaling seems to have opposite effects in SGLT1 trafficking, since diabetic rats 375 
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treated with subcutaneous insulin significantly decreased BBM SGLT1 levels without 376 
changes in mRNA [32]. Our results show that although sage tea only slightly affected 377 
PKC levels in enterocytes, RA significantly decreased its expression. RA by decreasing 378 
PKC levels may be contributing to retain SGLT1 in intracellular stores. However, 379 
further research is needed to clarify the molecular mechanism(s) behind S. fruticosa and 380 
RA effects on SGLT1 levels in BBM, and the involvement and relationship of both 381 
Hsp70 and PKC in this process. 382 
In conclusion, this study showed the ability of S. fruticosa to inhibit the adaptive 383 
increase of SGLT1 levels in BBM of rat enterocytes both after induction by STZ 384 
treatment and as a result of stimulation with HC diet. This effect appears to be due to 385 
modulation of SGLT1 trafficking by SFT, where RA seems to be the active principle. 386 
These data support previous reports on the antidiabetic effects of S. fruticosa, and 387 
emphasize the importance of the small intestine, and in particular the manipulation of 388 
BBM levels of SGLT1, in the therapeutic regulation of glucose homeostasis in diabetes. 389 
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 Figure captions 
 
Figure 1. Schematic representation of experimental designs. Experiment 1 (A): 
twenty-four rats were divided in to 4 groups of 6 animals each. STZ= streptozotocin; 
ip= intraperitoneal injection; Healthy= non-diabetic animals: Diabetic=STZ induced-
diabetic animals. SFT treatment was from day 14
th
 until 28
th
 of experiment. Double 
vertical lines on the right side of each group indicate terminal sampling.  
     healthy condition,      developing diabetes and      SFT/water treatment with 
established diabetic condition. Experiment 2 (B): thirty rats were divided into 5 groups 
with 6 animals each. Animals were fed either high-carbohydrate (HC) or low-
carbohydrate (LC) diets and given either water (W), S. fruticosa tea (SFT), or 
rosmarinic acid (RA) to drink according to the schematic representation. Double vertical 
lines at the right end of each group indicate terminal sampling. 
 
Figure 2. Effect of 14 days treatment with Salvia fruticosa tea (SFT) on fasting blood 
glucose (A), plasma insulin concentration (B) and liver glycogen content (C) of healthy 
(white bars) and STZ-induced diabetic (grey bars) animals. Values are means ± SEM, 
n=5-6. In A, diabetic rats showed high levels of blood glucose during the entire 
treatment period (from day 14
th
 until 28
th
) when compared with healthy animals 
(P≤0.001); **P≤0.01 when compared with diabetic water group by the Student t-test; 
NS, not significant (P>0.05) when compared with the respective water group (Student t-
test). In B, by two-way ANOVA, 
+++
P≤0.001 indicates that the difference between 
diabetic (W+SFT) and healthy (W+SFT) rats was significant; the post-hoc test Student 
Newman Keuls indicates significant differences:  
***
P≤0.001 and **P≤0.01 when 
compared with the respective healthy control. In C, no statistically significant 
differences were obtained among treatments. 
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Figure 3. Western blot analysis of SGLT1 expression in jejunal total extract (A) and 
brush-border membrane (BBM) (B) of healthy (white bars) and STZ-induced diabetic 
rats (grey bars) treated with water (W) or SFT. Representative immunoblot on BBM 
fraction from two animals from each treatment group is present.  Values are means ± 
SEM, n=5-6. Two-way ANOVA, indicates that the difference between diabetic 
(W+SFT) and healthy (W+SFT) rats was significant (
+++
P≤0.001). The post-hoc test 
Student Newman Keuls indicates significant differences: 
***
P≤0.001, **P≤0.01 and 
*
P≤0.05 when compared with the respective healthy control group, and ##P≤0.01 when 
compared with the diabetic water group. 
 
Figure 4. Western blot analysis of GLUT2 (A) and Na
+
/K
+
-ATPase (B) expression in 
jejunal whole cell homogenates of healthy (white bars) and STZ-induced diabetic rats 
(grey bars) treated with water (W) or SFT. Representative immunoblots of samples and 
corresponding loading control (beta-actin) from a pair of animals from each treatment 
group (A’ and B’) are present. Values are means ± SEM, n=5-6. Two-way ANOVA 
indicates that the difference between diabetic (W+SFT) and healthy (W+SFT) was 
significant (
+
P≤0.05 and ++P≤0.01). The post-hoc test Student-Newman-Keuls indicates 
significant differences: 
**
P≤0.01 when compared with the healthy water group.  
 
Figure 5. Plasma glucose concentration of water drinking (W) animals maintained on a 
high carbohydrate diet (HC-HC; black bar), changed from a HC to low carbohydrate 
(LC) diet (HC-LC; grey bar), and finally returned to a HC diet following LC diet (HC-
LC-HC; white bars). In addition to water drinking, HC-LC-HC animals were also given 
either sage tea (SFT) or rosmarinic acid (RA) ad libitum for the final 4 days on HC diet. 
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Values are means ± SEM, n= 6. Effect of carbohydrate diet: groups with the same letter 
notation are not significantly different from each other (P>0.05). Effect of drinking on 
HC-LC-HC groups (white bars): 
**
P≤0.01 when compared with the HC-LC-HC/W 
group and 
#
P≤0.05 when compared with HC-LC-HC/SFT group. 
 
Figure 6. Expression levels of SGLT1 protein in jejunal total extract (A) and brush-
border membrane (BBM) (B) from rats of the different treatment groups determined by 
Western blotting. Animals were feed either with their regular high carbohydrate (HC-
HC; black bars), changed from a HC to low carbohydrate (LC) diet (HC-LC; grey bar) 
or returned to a HC diet following LC diet (HC-LC-HC; white bar). In this latter 
feeding regime animals were given either drinking water (W), S. fruticosa tea (SFT) or 
rosmarinic acid (RA) ad libitum for 4 days. Representative blots of samples from a pair 
of animals from each treatment group are present. Values are means ± SEM, n= 6. 
Effect of carbohydrate diet: groups with the same letter notation are not significantly 
different from each other (P>0.05). Effect of drinking on HC-LC-HC groups (white 
bars): 
*
P≤0.05 and **P≤0.01 when compared with the HC-LC-HC/W group. 
 
Figure 7. Western blot analysis of Hsp70 expression in BBM of rats fed either their 
regular high carbohydrate (HC-HC; black bar), changed from a HC to low carbohydrate 
(LC) diet (HC-LC; grey bar) or returned to a HC diet following LC diet (HC-LC-HC; 
white bars). In this latter feeding regime animals were given either drinking water (W), 
S. fruticosa tea (SFT) or rosmarinic acid (RA) ad libitum for 4 days (A). Values are 
means ± SEM, n= 6. Effect of carbohydrate diet: groups with the same letter notation 
are not significantly different from each other (P>0.05). Effect of drinking on HC-LC-
HC groups (white bars): 
*
P≤0.05 when compared with the HC-LC-HC/W group. In (B), 
representative blot of samples from a pair of animals form each treatment group is 
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present. In (C), it is shown the difference on the expression levels of Hsp70 between 
whole cell homogenate (WCH) and BBM fraction from the same rat, loading 25 µg of 
protein each. 
 
Figure 8. Western blot analysis of PKC expression in small intestine whole cell 
homogenates from rats fed either their regular high carbohydrate (HC-HC; black bar), 
changed from a HC to low carbohydrate (LC) diet (HC-LC; grey bar) or returned to a 
HC diet following LC diet (HC-LC-HC; white bars). In this latter feeding regime 
animals were given either drinking water (W), S. fruticosa tea (SFT) or rosmarinic acid 
(RA) ad libitum for 4 days (A). Representative blots of samples and corresponding 
loading control (beta-actin) from a pair of animals form each treatment group are 
present (B). Values are means ± SEM, n= 6. Effect of carbohydrate diet: groups with 
the same letter notation are not significantly different from each other (P>0.05). Effect 
of drinking on HC-LC-HC groups (white bars): 
*
P≤0.05 when compared with the HC-
LC-HC/W group. 
 
